Preparation and pharmacokinetic study of mebendazole complex with HP-beta-cyclodextrin
Mebendazole, approved by the Food and Drug Administration (FDA) in 1974 to expel intestinal parasite infections, was found to exhibit multiple anti-cancer activities. However, due to its poor water solubility (0.33 ± 0.02 μg/mL), its clinical applications were greatly limited. Scientists at Wenzhou-...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Veterinary Science |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2025.1611154/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|